Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
002252.SZ Stock Price Chart
Explore Shanghai RAAS Blood Products Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002252.SZ price movements and trends.
002252.SZ Company Profile
Discover essential business fundamentals and corporate details for Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Jun 2008
Employees
3.35K
Website
https://www.raas-corp.comCEO
Jun Xu
Description
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
002252.SZ Financial Timeline
Browse a chronological timeline of Shanghai RAAS Blood Products Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 14 Jul 2025
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 14 Jul 2025.
Earnings released on 27 Apr 2025
EPS came in at ¥0.09 falling short of the estimated ¥0.10 by -10.00%, while revenue for the quarter reached ¥2.01B .
Earnings released on 17 Apr 2025
EPS came in at ¥0.05 falling short of the estimated ¥0.09 by -44.44%, while revenue for the quarter reached ¥1.86B , missing expectations by -24.03%.
Earnings released on 28 Oct 2024
EPS came in at ¥0.09 falling short of the estimated ¥0.10 by -10.00%, while revenue for the quarter reached ¥2.06B .
Dividend declared on 30 Sept 2024
A dividend of ¥0.04 per share was announced, adjusted to ¥0.04. The dividend was paid on 30 Sept 2024.
Earnings released on 27 Aug 2024
EPS came in at ¥0.07 falling short of the estimated ¥0.10 by -30.00%, while revenue for the quarter reached ¥2.18B .
Dividend declared on 5 Jun 2024
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 5 Jun 2024.
Earnings released on 28 Apr 2024
EPS came in at ¥0.11 surpassing the estimated ¥0.06 by +91.00%, while revenue for the quarter reached ¥2.04B .
Earnings released on 7 Feb 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥2.02B .
Earnings released on 24 Oct 2023
EPS came in at ¥0.08 , while revenue for the quarter reached ¥2.03B .
Earnings released on 29 Aug 2023
EPS came in at ¥0.08 , while revenue for the quarter reached ¥1.84B .
Dividend declared on 13 Jun 2023
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 13 Jun 2023.
Earnings released on 28 Apr 2023
EPS came in at ¥0.11 , while revenue for the quarter reached ¥2.06B .
Earnings released on 25 Apr 2023
EPS came in at ¥0.04 , while revenue for the quarter reached ¥1.62B .
Earnings released on 30 Sept 2022
EPS came in at ¥0.08 , while revenue for the quarter reached ¥1.66B .
Dividend declared on 7 Jul 2022
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 7 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.08 , while revenue for the quarter reached ¥1.61B .
Earnings released on 22 Apr 2022
EPS came in at -¥0.02 falling short of the estimated ¥0.09 by -116.79%, while revenue for the quarter reached ¥1.24B .
Earnings released on 31 Mar 2022
EPS came in at ¥0.08 , while revenue for the quarter reached ¥1.69B .
Earnings released on 30 Sept 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥1.29B .
Dividend declared on 2 Jul 2021
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 2 Jul 2021.
Earnings released on 30 Jun 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥901.52M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.06 , while revenue for the quarter reached ¥854.21M .
Earnings released on 31 Dec 2020
EPS came in at ¥0.03 , while revenue for the quarter reached ¥723.62M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.06 , while revenue for the quarter reached ¥728.75M .
002252.SZ Stock Performance
Access detailed 002252.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.